Lwin Thu Zar, Durant Jason J, Bashford Donald
Hartwell Center for Bioinformatics and Biotechnology, Saint Jude Children's Research Hospital, 322 N. Lauderdale St., Mail Stop 312, Memphis, TN 38105, USA.
J Mol Biol. 2007 Nov 9;373(5):1334-47. doi: 10.1016/j.jmb.2007.07.080. Epub 2007 Aug 24.
p53 is a homotetrameric tumor suppressor protein that is found to be mutated in most human cancers. Some of these mutations, particularly mutations to R337, fall in the tetramerization domain and cause defects in tetramer formation leading to loss of function. Mutation to His at this site has been found to destabilize the tetramer in a pH-dependent fashion. In structures of the tetramerization domain determined by crystallography, R337 from one monomer makes a salt bridge with D352 from another monomer, apparently helping to stabilize the tetramer. Here we present molecular dynamics simulations of wild-type p53 and the R337His mutant at several different pH and salt conditions. We find that the 337-352 salt bridge is joined by two other charged side chains, R333 and E349. These four residues do not settle into a fixed pattern of salt bridging, but continue to exchange salt-bridging partners on the nanosecond time scale throughout the simulation. This unusual system of fluid salt bridging may explain the previous finding from alanine scanning experiments that R333 contributes significantly to protein stability, even though in the crystal structure it is extended outward into solvent. This extended conformation of R333 appears to be the result of a specific crystal contact and, this contact being absent in the simulation, R333 turns inward to join its interaction partners. When R337 is mutated to His but remains positively charged, it maintains the original interaction with D352, but the newly observed interaction with E349 is weakened, accounting for the reduced stability of R337H even under mildly acidic conditions. When this His is deprotonated, the interaction with D352 is also lost, accounting for the further destabilization observed under mildly alkaline conditions. Simulations were carried out using both explicit and implicit solvent models, and both displayed similar behavior of the fluid salt-bridging cluster, suggesting that implicit solvent models can capture at least the qualitative features of this phenomenon as well as explicit solvent. Simulations under strongly acidic conditions in implicit solvent displayed the beginnings of the unfolding process, a destabilization of the hydrophobic dimer-dimer interface. Computational alanine scanning using the molecular mechanics Poisson-Boltzmann surface area method showed significant correlation to experimental unfolding data for charged and polar residues, but much weaker correlation for hydrophobic residues.
p53是一种同四聚体肿瘤抑制蛋白,在大多数人类癌症中都发现其发生了突变。其中一些突变,特别是R337位点的突变,位于四聚化结构域,导致四聚体形成缺陷,进而导致功能丧失。已发现该位点突变为组氨酸会以pH依赖的方式使四聚体不稳定。在通过晶体学确定的四聚化结构域结构中,一个单体的R337与另一个单体的D352形成盐桥,显然有助于稳定四聚体。在此,我们展示了野生型p53和R337His突变体在几种不同pH和盐条件下的分子动力学模拟。我们发现337 - 352盐桥由另外两个带电荷的侧链R333和E349连接。在整个模拟过程中,这四个残基并未形成固定的盐桥模式,而是在纳秒时间尺度上持续交换盐桥伙伴。这种不同寻常的流体盐桥系统可能解释了先前丙氨酸扫描实验的发现,即R333对蛋白质稳定性有显著贡献,尽管在晶体结构中它向外延伸到溶剂中。R333的这种延伸构象似乎是特定晶体接触的结果,由于模拟中不存在这种接触,R333向内翻转以与它的相互作用伙伴结合。当R337突变为组氨酸但仍带正电荷时,它与D352保持原始相互作用,但新观察到的与E349的相互作用减弱,这解释了即使在轻度酸性条件下R337H稳定性降低的原因。当这个组氨酸去质子化时,与D352的相互作用也会丧失,这解释了在轻度碱性条件下观察到的进一步不稳定现象。使用显式和隐式溶剂模型都进行了模拟,并且两者都显示出流体盐桥簇的类似行为,这表明隐式溶剂模型至少可以捕捉到这种现象的定性特征以及显式溶剂模型。在隐式溶剂中强酸性条件下的模拟显示出解折叠过程的开端,即疏水二聚体二聚体界面的不稳定。使用分子力学泊松 - 玻尔兹曼表面积方法进行的计算丙氨酸扫描显示,对于带电荷和极性残基,与实验解折叠数据有显著相关性,但对于疏水残基相关性较弱。